Here, we found that more advanced cervical cancers, patients with lymph node metastases or who retrospectively developed cervical cancer recurrence exhibited stronger AKT phosphorylation in situ (Fig. S6C‐H). This evidence concerns the gene AKT1 and cervical cancer.